An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: Protocol for a cluster randomized controlled trial

Implementation Science

Volumn 11, Issue 1, 2016, Pages

  Hayek, Adina ^a,b   Joshi, Rohina ^a,b   Usherwood, Tim ^a,b,c   Webster, Ruth ^a,b   Kaur, Baldeep ^a,b   Saini, Bandana ^d,e   Armour, Carol ^d,e   Krass, Ines ^e   Laba, Tracey Lea ^a,b   Reid, Christopher ^f,g   Shiel, Louise ^f   Hespe, Charlotte ^h   Hersch, Fred ⁱ   Jan, Stephen ^a,b   Lo, Serigne ^a,b   Peiris, David ^a,b   Rodgers, Anthony ^a,b   Patel, Anushka ^a,b  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Woolcock Institute for Medical Research   (Australia)

^e University of Sydney   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g CURTIN UNIVERSITY   (Australia)

^h UNIVERSITY OF NOTRE DAME   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cardiovascular disease; Clinical decision support system; General practitioners; Pharmacists; Polypill; Primary health care

Indexed keywords

EID: 84992083983     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-016-0488-1     Document Type: Article

References (42)

1. World Health Organisation. Australia. Noncommunicable diseases (NCD) country profiles 2014. Geneva: WHO; 2015. http://who.int/countries/aus/en/. Accessed 23 September 2015.
2. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527-35.
3. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.[Erratum appears in Lancet. 2008;371:2084, Erratum appears in Lancet. 2005;366:1358]. Lancet. 2005;366:1267-78.
4. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.[Erratum appears in BMJ 2002;324:141]. BMJ. 2002;324:71-86.
5. Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-60.
6. Webster RJ, Heeley EL, Peiris DP, Bayram C, Cass A, Patel AA. Gaps in cardiovascular disease risk management in Australian general practice. MJA. 2009;191:324-9.
7. Heeley EL, Peiris DP, Patel AA, Cass A, Weekes A, Morgan C, et al. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). MJA. 2010;192:254-9.
8. Houston Miller N, Hill M, Kottke T, Ockene IS, For the Expert Panel on Compliance. The multilevel compliance challenge: recommendations for a call to action. Circulation. 1997;95:1085-90.
9. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008. doi: 10.1002/14651858.CD000011.pub3.
10. Peiris D, Usherwood T, Panaretto K, Harris M, Hunt J, Patel B, et al. The Treatment of cardiovascular Risk in Primary care using Electronic Decision suppOrt (TORPEDO) study: intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open. 2012;2:e002177.
11. Peiris D, Usherwood T, Panaretto K, Harris M, Hunt J, Redfern J, et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk managment in primary health care. The treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circ Cardiovasc Qual Outcomes. 2015;8:87-95.
12. Webster R, Patel A, Selak V, Billot L, Bots ML, Brown A, et al. Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: a prospective, individual patient data meta-analysis of 3140 patients in six countries. Int J Cardiol. 2016;205:147-56.
13. The Pharmacy Guild of Australia. Community pharmacy roadmap program development template: QUM and continuity of care. http://www.guild.org.au/docs/default-source/public-documents/tab---the-guild/strategic-direction/qum-continuity-of-care.pdf?sfvrsn=0. Accessed 15 June 2016.
14. Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77:102-15.
15. Ho P, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174:186-93.
16. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296:2563-71.
17. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310:46-56.
18. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62:496-502.
19. Mitchell B, Armour C, Lee M, Song YJ, Stewart K, Peterson G, et al. Diabetes medication assistance service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Educ Counsel. 2011;83:288-94.
20. Svarstad BL, Kotchen JM, Shireman TI, Brown RL, Crawford SY, Mount JK, et al. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial. J Am Pharm Assoc. 2013;53:520-9.
21. Wentzlaff DM, Carter BL, Ardery G, Franciscus CL, Doucette WR, Chrischilles EA, et al. Sustained blood pressure control following discontinuation of a pharmacist intervention. J Clin Hypertens. 2011;13:431-7.
22. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748-55.
23. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. AJHP. 2011;68:241-53.
24. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:1-12.
25. Patel B, Patel A, Jan S, Usherwood T, Harris M, Panaretto K, et al. A multifaceted quality improvement intervention for CVD risk management in Australian primary healthcare: a protocol for a process evaluation. Implement Sci. 2014;9:187.
26. Peiris DP, Joshi R, Webster RJ, Groenstein P, Usherwood TP, Heeley E, et al. An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation. J Med Internet Res. 2009;11:e51.
27. Jan S, Usherwood T, Brien JA, Peiris D, Rose J, Hayman N, et al. What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study. BMJ Open. 2011;1:e000372.
28. PEN CS. CAT Plus. http://www.pencs.com.au/cat-plus/. Accessed 15 June 2016.
29. Peiris D, Usherwood T, Weeramanthri T, Cass A, Patel A. New tools for an old trade: a socio-technical appraisal of how electronic decision support is used by primary care practitioners. Sociol Health Illn. 2011;33:1002-18.
30. Commonwealth of Australia. Towards responsible government. Appendix to the report of the National Commission of Audit. Volume 1. 9.4 The Pharmaceutical Benefits Scheme. 2014; http://www.ncoa.gov.au/report/docs/appendix_volume%201.pdf. Accessed 18 April 2016.
31. Australian Government Department of Health. The Pharmaceutical Benefits Scheme. Pharmaceutical benefits: fees, patient contributions and safety net thresholds. 2016; http://www.pbs.gov.au/info/healthpro/explanatory-notes/front/fee. Accessed 6 June 2016.
32. Australian Government Department of Health. The Pharmaceutical Benefits Scheme: the safety net scheme. 2016; http://www.pbs.gov.au/info/healthpro/explanatory-notes/section1/Section_1_5_Explanatory_Notes. Accessed 16 June 2016.
33. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348-54.
34. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15:59-66.
35. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: final response. J Clin Epidemiol. 2011;64:262-3.
36. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113-24.
37. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.
38. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. 2012. http://www.cvdcheck.org.au/pdf/Absolute_CVD_Risk_Full_Guidelines.pdf. Accessed 15 December 2015.
39. Australian Institute of Health and Welfare. Rural, remote and metropolitan areas (RRMA) classification. 2016; http://www.aihw.gov.au/rural-health-rrma-classification/. Accessed 22 June 2016.
40. Kellogg Foundation WK. Logic model development guide. 2004. http://www.smartgivers.org/uploads/logicmodelguidepdf.pdf. Accessed 18 April 2016.
41. The Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice, 8th Edition. East Melbourne, 2012. http://www.nmml.org.au/content/Document/RACGP%20Red%20Book.pdf. Accessed 30 June 2016.
42. The Royal Australian College of General Practitioners. Vision for general practice and a sustainable healthcare system. Melbourne: RACGP;2015. http://www.racgp.org.au/download/Documents/advocacy/racgp-vision-for-general-practice-and-a-sustainable-health-system.pdf. Accessed 30 June 2016.